IRIS
AMATO, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.544
AS - Asia 2.881
NA - Nord America 2.382
SA - Sud America 469
AF - Africa 79
OC - Oceania 6
Totale 9.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.261
SG - Singapore 1.540
IT - Italia 1.488
RU - Federazione Russa 1.196
CN - Cina 638
BR - Brasile 399
VN - Vietnam 289
HK - Hong Kong 213
FR - Francia 150
DE - Germania 140
NL - Olanda 137
FI - Finlandia 91
GB - Regno Unito 89
CA - Canada 60
IE - Irlanda 57
IN - India 43
MX - Messico 41
AR - Argentina 33
CI - Costa d'Avorio 30
PL - Polonia 29
BD - Bangladesh 26
AT - Austria 23
SE - Svezia 23
KR - Corea 22
ZA - Sudafrica 21
ES - Italia 20
IQ - Iraq 18
JP - Giappone 18
UA - Ucraina 18
HU - Ungheria 16
LT - Lituania 15
CO - Colombia 12
ID - Indonesia 12
TR - Turchia 12
EC - Ecuador 11
BE - Belgio 7
MA - Marocco 7
MT - Malta 7
CZ - Repubblica Ceca 6
IL - Israele 6
IR - Iran 6
PK - Pakistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DK - Danimarca 5
CR - Costa Rica 4
LU - Lussemburgo 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BY - Bielorussia 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
LY - Libia 3
MK - Macedonia 3
NP - Nepal 3
PY - Paraguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CM - Camerun 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PT - Portogallo 1
Totale 9.354
Salva come PNG Salva come JPEG
Città #
Singapore 721
Moscow 283
Chandler 267
Ashburn 239
Naples 217
Beijing 213
Hong Kong 210
Napoli 210
Santa Clara 120
Amsterdam 109
Hefei 104
Los Angeles 76
Dong Ket 74
Ho Chi Minh City 67
Millbury 65
Boston 53
Milan 50
Munich 49
Rome 48
Des Moines 47
Hanoi 47
New York 46
São Paulo 46
Princeton 44
Nanjing 39
Buffalo 34
Redondo Beach 32
Lawrence 30
Turku 24
Brooklyn 23
Dallas 23
Houston 23
Warsaw 23
Seattle 22
Chicago 21
Montreal 21
Mexico City 20
Ottawa 20
Seoul 20
Tampa 20
The Dalles 20
Wilmington 20
Denver 19
Nuremberg 19
Atlanta 18
Stockholm 18
Tokyo 17
Helsinki 16
Ottaviano 16
Poplar 16
Ercolano 15
Manchester 15
Orem 15
Lappeenranta 14
Phoenix 14
Bologna 13
London 13
Abbiategrasso 12
Frankfurt am Main 12
San Jose 12
Boardman 11
Da Nang 11
Formia 11
Washington 11
Johannesburg 10
Nanchang 10
Redwood City 10
Rio de Janeiro 10
Brasília 9
Chennai 9
Hebei 9
Hải Dương 9
Jiaxing 9
Vienna 9
Afragola 8
Baghdad 8
Budapest 8
Charlotte 8
Falkenstein 8
Hangzhou 8
Marsala 8
Nocera Inferiore 8
Palermo 8
Pavia 8
San Francisco 8
Shenyang 8
Biên Hòa 7
Dhaka 7
Ferrara 7
Guangzhou 7
Melita 7
Melito Di Napoli 7
Mumbai 7
Ninh Bình 7
Norwalk 7
Pune 7
Querétaro 7
Salvador 7
Tianjin 7
Ankara 6
Totale 4.445
Salva come PNG Salva come JPEG
Nome #
Analisi qualitativa e quantitativa di splicing alternativi mediante una singola reazione di droplet digital PCR 446
MicroRNA come target terapeutici per il trattamento della fibrosi cistica 223
CFTR expression during cellular senescence 174
3D Chitosan-Gallic Acid Complexes: Assessment of the Chemical and Biological Properties 169
Enhanced frequency of CFTR gene variants in couples who are candidates for assisted reproductive technology treatment. 165
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 165
Economical, legal and ethical considerations on reevaluation and retesting in molecular diagnostics 163
Clinical implication of cellular senescence on CFTR expression. 158
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. [*Coretti L. corresponding author] 156
Olfactory performance in Cystic Fibrosis patients 145
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 139
Epigenetica, diagnostica e terapia della fibrosi cistica 135
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 130
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 130
Cystic Fibrosis: The Sense of Smell 130
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 127
Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims 127
Cystic Fibrosis: the sense of smell. 127
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 127
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 126
Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults 123
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR 120
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization 120
Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression 118
CONVERSIONE GENICA FRA I GENI CODIFICANTI IL TRIPSINOGENO PRSS1 E PRSS2: UN EVENTO RICOMBINANTE RARO IN DUE PAZIENTI PEDIATRICI. 118
A Novel DHPLC-Based Procedure for the Analysis of COL1A1 and COL1A2 Mutations in Osteogenesis Imperfecta. 117
Letter to the Editor: Is there an Indication for Testing the Methylenetetrahydrofolate reductase A1298C Variant in Routine Clinical Settings? 117
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 115
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 114
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells 114
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 113
Valutazione degli effetti del butirrato sulla fisiologia intestinale mediante real-time PCR. 112
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium 108
Extensive molecular analysis of patients bearing CFTR-related disorders. 108
Qualitative and quantitative evaluation of alternative splicing products using the digital droplet PCR 108
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 108
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 107
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 106
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 106
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 105
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: Implications for recurrence risk and prenatal diagnosis. 105
The implication of MBL deficient haplotypes in acute coronary syndrome. 104
Two cases of microvillous inclusion disease caused by novel mutations in MYO5B gene 104
Target Protector PNA: a new tool in Cystic Fibrosis treatment 103
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 102
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 102
Analisi molecolare della nuova variante allelica T4Gnella regione 4G/5G del promotore del gene PAI-1. 101
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 100
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 99
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel 98
Epigenetic effects of butyrate in children with congenital chloride diarrhea: an in-vivo and in-vitro study. 97
An Update on Laboratory Diagnosis of Liver Inherited Diseases 97
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 96
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. 96
Genetic Diseases That Predispose to Early Liver Cirrhosis 96
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 96
Prothrombotic gene variants in acute myocardial infarction at a young age (yAMI). Rationale for tailored prevention strategies in specific risk-group subjects for acute coronary disease? 94
The role of functional studies in the diagnosis and treatment of Cystic Fibrosis: comparing the case of the G970D and G970R mutation. 94
Molecular analysis of prothrombotic gene variants in patients with acute ischemic stroke and with transient ischemic attack 94
GENOTYPE PREDICTS THE RESPONSE TO THERAPY IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA. 89
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 89
Identificazionee caratterizzazione di mutazioni in regioni regolatorie del gene malattia della fibrosi cistica 88
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy 86
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 86
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients. 85
Haemophilia A: the consequences of de novo mutations. Two case reports 85
Cystic fibrosis, molecular genetics for all life 84
BUTYRATE MODULATES EPITHELIAL DRA EXPRESSION IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA 83
Ricerca di fattori trascrizionali allele specifici per due nuove varianti riscontrate nelle CSTs di CFTR. 83
Sars-cov-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of sars-cov-2 variants 82
The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases 80
Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? 78
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor? 77
Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 76
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 76
Patient-derived cell models for personalized medicine approaches in cystic fibrosis 74
Lung microbiome in cystic fibrosis 68
The friendly use of chloroquine in the COVID-19 disease: A warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene 66
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in three subjects with the cystic fibrosis genotype phe508del/unknown and advanced lung disease 63
Congenital diarrheal disorders: an updated diagnostic approach 60
Molecular and Functional Analysis of the Large 5' Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders. 60
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response. 58
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea 55
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype 53
Porphyromonas somerae in urinary microbiome and its potential metabolic role in bladder cancer 52
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 51
The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control 51
Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells 40
Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator-related disorders (congenital bilateral absence of vas deferens) 39
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 37
Mouse intestine as a useful model for CFTR electrophysiology function analysis 19
null 12
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 11
Mechanisms of action of butyrate in congenital chloride diarrhea (CLD) 3
Totale 9.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 0 16 40 21 35 27 95
2021/2022707 51 27 14 26 7 32 13 37 93 113 127 167
2022/2023782 76 52 31 65 75 74 39 68 105 117 62 18
2023/2024623 29 77 90 43 39 59 36 59 27 32 72 60
2024/20252.844 149 142 20 78 107 178 268 218 145 308 1.008 223
2025/20263.437 559 376 552 637 1.054 250 9 0 0 0 0 0
Totale 9.596